Is MHRA enabling mRNA and adenovirus injections by changing its regulations?

Yes, and here is the evidence...

SARS-CoV-2 jabs are Advanced Therapy Medicinal Products (ATMPs)

In a recent email, we drilled down into cell and gene therapies in the EU/UK, and what the link was with SARS-CoV-2 injections. Read more here:

What are cell and gene therapies and what's the connection with SARS-CoV-2 jabs?

This extract provides the clue:

“SARS-CoV-2 injections are gene therapies, so they must be ATMPs

We already know SARS-CoV-2 injections are gene therapies, as confirmed by UK Government in an announcement in March on a Government grant of £15.9 million awarded to lipid producer Croda: Government to provide shot in the arm for West Midlands vaccine manufacturing facility, commenting:

“lipids are an essential component in COVID vaccines as well as ‘other’ gene therapies””

This link to the MHRA Website clinches it:

Advanced therapy medicinal products: regulation and licensing:

“An advanced therapy medicinal product (ATMP) is a medicinal product which is either:

• a gene therapy medicinal product

• a somatic cell therapy…